Study details
Enrolling now
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
University of Alabama at Birmingham
NCT IDNCT05437588ClinicalTrials.gov data as of Apr 2026
Target enrollment
240
Study length
about 4.7 years
Ages
10–24
Locations
2 sites in AL
About this study
This trial is testing if certain molecules, called microRNAs, found in blood can help predict how well people respond to treatment for depression and suicide. The goal is to find better ways to diagnose and treat these conditions.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Genetic testing
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low14%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Psychiatry / Mental Health